Latest Strategy News

New Murchison Gold (ASX:NMG) has uncovered its deepest and highest-grade gold intercept to date below the Crown Prince open pit, underscoring significant underground mining potential at its flagship Garden Gully project.

Canyon Resources has mobilised its surface miner at the Minim Martap Bauxite Project, with first production on track for Q2 2026 and full funding secured through a US$140 million credit facility and cash reserves. Leadership changes and logistics updates mark a pivotal quarter for the company.

DigitalX Limited closed the March 2026 quarter with A$59.5 million in liquid assets, unveiling a A$30 million strategic investment program and delivering record revenue from its Sell My Shares platform, signalling a pivot towards disciplined capital deployment and sustainable growth.

Doctor Care Anywhere posted an 8.4% quarterly jump in consultations and sustained positive cashflow for the fourth consecutive quarter, while launching new digital health initiatives and reaffirming its medium-term revenue and profitability targets.

Burley Minerals has reignited interest in its Chubb Lithium Project in Quebec following a lithium price uptick and promising drilling results revealing both spodumene and rare pollucite mineralisation. The company is weighing strategic options including further exploration, joint ventures, or sale.

Cavalier Resources has secured a $4 million placement at an 11.95% discount to the 15-day VWAP, funding critical pre-production activities at its Crawford Gold Project. This capital injection complements ongoing negotiations for a US$13 million gold prepayment and a A$5 million loan, advancing the project toward production.

Tolu Minerals has raised AUD 23.75 million through convertible notes from Petrosea, reinforcing its capital position ahead of shareholder approval. The company is also shoring up diesel supplies to safeguard operations at its Tolukuma Gold Mine amid global fuel volatility, while early drilling results hint at further resource potential.

Radiopharm Theranostics (ASX: RAD) has completed enrolment in its Phase 2b RAD 101 brain metastases imaging trial with interim data showing 90% concordance with MRI, while progressing early-stage trials of therapeutic candidates RAD 202, RV-01, and RAD 402. The company reported a $19.2 million cash balance at quarter end, down from $34.5 million, with a net operating cash outflow of $14.9 million driven by milestone-related R&D and staff costs.

Barton Gold has launched a ~3,000m diamond drilling campaign at its Tunkillia project, aiming to upgrade resources and support a Mining Lease application by the end of 2026. The project builds on a strong May 2025 study projecting robust returns amid rising gold and silver prices.

XRF Scientific is set to broaden its industrial reach by acquiring Bruker’s Combustion Gas Analysis business for USD 4 million, adding a profitable product line and new market sectors.

Delta Lithium’s March quarter report highlights robust high-grade lithium drilling at Mt Ida, successful production of battery-grade lithium and rubidium carbonates, and ongoing exploration progress at Yinnetharra, supported by a strong $52 million cash position.

Pantoro Gold has struck a $20 million funding deal with Mega Resources to develop the high-grade Rama Open Pit in Western Australia, securing an exclusive option to extend mining underground through a profit-sharing agreement.